Adelaide Research & Scholarship: Browsing DSpace

Browsing "Pharmacology" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 488 to 507 of 918 < previous next >

Issue Date	Title	Author(s)
2009	LAAM in the treatment of opioid dependence: a systematic review	Clark, N.; Gijsbers, A.; White, Jason Mark
2009	Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRMI) and opioid defendence: A meta-analysis	Coller, J.; Beardsley, J.; Bignold, J.; Li, Y.; Merg, F.; Sullivan, T.; Cox, T.; Somogyi, A.
2001	Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects	Moller, S.; Larsen, F.; Khant, A.; Rolan, P.
1995	Lack of effect of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen in human.	Knights, K.; McLean, C.; Tonkin, A.; Miners, J.
2007	Lack of influence of CYP2D6 genotype on the clearance of (R)- (S)- and racemic-methadon	Coller, J.; Joergensen, C.; Foster, D.; James, H.; Gillis, D.; Christrup, L.; Somogyi, A.
2003	Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects	Ferron, G.; Patat, A.; Parks, V.; Rolan, P.; Troy, S.
1998	Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service	Morris, R.; Black, A.; Harris, A.; Batty, A.; Sallustio, B.
2004	Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity	Coller, J.; Krebsfaenger, N.; Klein, K.; Wolbold, R.; Nussler, A.; Neuhaus, P.; Zanger, U.; Eichelbaum, M.; Murdter, T.
2021	Large variability in plasma efavirenz concentration in Papua New Guinea HIV/AIDS patients associated with high frequency of CYP2B6 516T allele	Bordin Andriguetti, N.; Van Schalkwyk, H.K.; Barratt, D.T.; Tucci, J.; Pumuye, P.; Somogyi, A.A.
1999	Laws applying to minor cannabis offences in Australia and their evaluation	Lenton, S.; McDonald, D.; Ali, R.; Moore, T.
2005	LC mass spectrometry	Morris, R.; Taylor, P.
2010	LC-MS/MS for immunosuppressant therapeutic drug monitoring	Sallustio, B.
2014	Lethal hepatocellular necrosis associated with herbal polypharmacy in a patient with chronic hepatitis B infection	Gilbert, J.; Musgrave, I.; Hoban, C.; Byard, R.
2018	LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence	Ezard, N.; Dunlop, A.; Hall, M.; Ali, R.; McKetin, R.; Bruno, R.; Phung, N.; Carr, A.; White, J.; Clifford, B.; Liu, Z.; Shanahan, M.; Dolan, K.; Baker, A.L.; Lintzeris, N.
2009	Limited uptake of the cyanobacterial toxin cylindrospermopsin by Vero cells	Froscio, S.; Cannon, E.; Lau, H.; Humpage, A.
2007	'Listening' and 'talking' to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids	Watkins, L.; Hutchinson, M.; Milligan, E.; Maier, S.
2014	Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment	Jelinic, M.; Leo, C.H.; Post Uiterweer, E.D.; Sandow, S.L.; Gooi, J.H.; Wlodek, M.E.; Conrad, K.P.; Parkington, H.; Tare, M.; Parry, L.J.
2000	Long-term abecarnil administration produces tolerance and withdrawal signs in the rat	Elliot, Elizabeth Emily; White, Jason Mark
2004	Long-term follow-up using a higher target range for lamotrigine monitoring	Morris, R.; Lee, M.; Cleanthous, X.; Black, A.
2001	Longchain n-3 polyunsaturated fatty acids and blood vessel function	Abeywardena, M.; Head, R.

Showing results 488 to 507 of 918 < previous next >